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Abstract
Aims: This study investigated the trends and levels of the prevalence of health
factors, and the association of all-cause and cardiovascular (CVD) mortality with
healthy levels of combined risk factors among Lithuanian urban population.
Methods: Data from five general population surveys in Kaunas, Lithuania,
conducted between 1983 and 2008 were used. Healthy factors measured at
baseline include non-smoking, normal weight, normal arterial blood pressure,
normal level of total serum cholesterol, normal physical activity and normal level of
fasting glucose. Among 9,209 men and women aged 45–64 (7,648 were free from
coronary heart disease (CHD) and stroke at baseline), 1,219 death cases from any
cause, 589 deaths from CVD, and 342 deaths from CHD occurred during follow up.
Cox proportional hazards regression was used to estimate the association between
health factors and mortality from all causes, CVD and CHD.
Results: Between 1983 and 2008, the proportion of subjects with 6 healthy levels
of risk factors was higher in 2006–2008 than in 1983–1984 (0.6% vs. 0.2%;
p50.09), although there was a significant increase in fasting glucose and a decline
in intermediate physical activity. Men and women with normal or intermediate levels
of risk factors had significantly lower all-cause, CVD and CHD mortality risk than
persons with high levels of risk factors. Subjects with 5–6 healthy factors had
hazard ratio (HR) of CVD mortality 0.35 (95% confidence interval (CI) 0.15–0.83)
compared to average risk in the whole population. The hazard ratio for CVD
mortality risk was significant in men (HR 0.34, 95% CI 0.12–0.97) but not in women
(HR 0.38, 95% CI 0.09–1.67).
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Conclusions: An inverse association of most healthy levels of cardiovascular risk
factors with risk of all-cause and CVD mortality was observed in this urban
population-based cohort. A greater number of cardiovascular health factors were
related with significantly lower risk of CVD mortality, particularly among men.
Introduction
Despite the decline in age-standardized death rates over the recent decades in
high-income countries, cardiovascular diseases (CVD), including coronary heart
disease (CHD) and stroke, and cancer continue to be the leading causes of
morbidity and mortality in the United States, most Western and Eastern countries
[1–3]. The reductions in mortality and morbidity due to CVD and other non-
communicable diseases can be attributed to several factors, including improve-
ments in modifiable risk factors [4, 5].
Recently, new data from several studies have demonstrated the benefits of
favourable levels of modifiable risk factors, so called cardiovascular health factors,
for all-cause death rates and CVD mortality or morbidity [6–8]. Several studies,
mainly in the US, have shown that alarmingly few adults participating in cohort
studies achieved the favourable levels of all 7 most frequently measured CVD risk
factors: physically activity, normal blood pressure, glucose and total cholesterol
levels, body weight, and healthy diet [6, 9, 10].
In Lithuania, CVD incidence and mortality rates among both women and men
are higher than in western European countries [11, 12]. In 2010, the mortality
rates from CHD were 429 per 100,000 men and 239 per 100,000 women in
Lithuania, compared with 210 per 100,000 for men and 114 per 100,000 women in
27 countries of the European Union [13]. Epidemiological studies in Lithuanian
population samples indicate a high prevalence of most lifestyle (smoking,
overweight and obesity, unhealthy nutrition habits, physical inactivity) and other
modifiable risk factors of CVD (hypercholesterolemia, arterial hypertension)
[14, 15]. The prognostic value of these risk factors in the incidence and mortality
from CHD, stroke and other non-communicable diseases in Lithuania has been
demonstrated to be similar to other populations [16–18]. However, risk factors
have been studied separately and their combined effects have not been assessed.
The aim of this study was to estimate the trend and levels of the prevalence of
health factors, and to evaluate the risk of all-cause and CVD mortality in relation
to healthy levels of combined risk factors among middle aged Lithuanian urban
population.
Health Factors and Risk of Mortality
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Methods
Study sample
Data from the five studies were used in these analyses. The first three surveys of
the Lithuanian Multinational Monitoring of Trends and Determinants in
Cardiovascular Disease (MONICA) Programme were performed in 1983–1984,
1986–1987 and 1992–1993; the post-MONICA survey was conducted in 2001–
2002 using the MONICA protocol, and the 2006–2008 Health, Alcohol and
Psychosocial Factors in Eastern Europe (HAPIEE) study adopted measures very
similar to the MONICA Project [19]. All these surveys were carried out in Kaunas,
the second largest Lithuanian city (population 348,624 people). All five surveys
examined random samples of men and women aged, stratified by gender and age,
randomly selected from the Kaunas population register. The response rates were
70.2%, 69.6%, 58.6%, 62.4%, 58.1%, respectively. A total of 9,209 subjects (7,648
were free from CHD and stroke at baseline) aged 45–64 at baseline were available
for statistical analysis. All respondents provided written informed consent. All five
studies were approved by the Regional Biomedical Research Ethics Committee at
the Lithuanian University of Health Sciences and the HAPIEE study (2006–2008)
- also by the UCLH Research Ethics Committee Alpha at University College
London, UK.
Baseline health examination
In each survey, blood pressure (BP), weight, height, and biomarkers were
measured using the same methodology. The information and variables
determined using the questionnaire was based on identical or very similar
questionnaires.
Measurements
BP was measured two times using mercury sphygmomanometer and appro-
priately sized arm cuffs on the right arm. The initial measurement was performed
after five minutes of rest on the right arm. After two minutes, the second
measurement was made. The Korotkoff phase 1 (beginning of the sound) and the
fifth phase of Korotkoff (disappearance of the sound) was recorded as systolic and
diastolic BP. The mean of two readings was used. Hypertension was defined as
mean systolic BP of at least 140 mm Hg or mean diastolic BP of at least 90 mm
Hg, or both, and/or using antihypertensive medication in the last two weeks.
Weight and height were measured with a calibrated medical scale, and without
shoes or heavy clothes. Body mass index (BMI) was calculated as the weight in
kilograms divided by the height in meters squared (kg/m2). Normal weight was
defined as BMI,25.0 kg/m2, overweight as BMI>25.0–29.99 kg/m2 and obesity
as BMI>30.0 kg/m2.
Health Factors and Risk of Mortality
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Laboratory analyses
Fasting serum samples from first four surveys were analyzed in the Laboratory of
the Institute of Cardiology of the Lithuanian University of Health Sciences; serum
samples from the fifth survey were analysed in one batch in the WHO Regional
Lipid Reference Centre, Institute of Clinical and Experimental Medicine, Prague
(Czech Republic). Lipid concentrations in serum were measured by conventional
enzymatic method. Subjects were classified into three groups according to their
total cholesterol level: normal (,5.2 mmol/L), intermediate (5.2–6.19 mmol/L),
and increased level (equal 6.2 mmol/L or more). Concentration of glucose in
capillary blood was determined by an individual glucometer ‘‘Glucotrend’’ [20].
Normal glucose level was defined as fasting glucose ,5.55 mmo/L, intermediate
as glucose level 5.55–6.98 mmol/L and increased as glucose level equal
6.99 mmol/L or more [6, 20].
Variables determined using the questionnaire
The structured questionnaire included questions regarding the respondent’s age,
education, smoking status, alcohol consumption, physical activity, antihyperten-
sive treatment, hypoglycemic therapy, lipid lowering treatment, and other factors.
Education was classified into four education levels: primary, vocational, secondary
or college and university. Smoking status was classified as never smokers, former
smokers and current smokers (at least one cigarette per day). Alcohol
consumption frequency was classified into six groups: never or former drinkers,
drinkers less than once per month, 1–3 times per month, once per week, 2–3 times
per week, several times per week or daily. Physical activity was determined by
weekly hours of leisure activity in winter and summer (e.g. walking, moderate and
hard work, gardening and other physical activities). The respondents were
categorized into three groups according to their physical activity in leisure time:
active (7 and more hours/week), intermediate (2.0–6.99 hours/week), and inactive
(,2.0 hours/week).
Healthy factors
Healthy factors measured at baseline include non-smoking, normal weight,
normal arterial blood pressure, normal level of total serum cholesterol, normal
physical activity and normal level of fasting glucose.
Follow-up
Participants (aged 45–64) of the five surveys form the analytical cohort. Deaths
among the participants between the baseline (of the relevant survey) until the end
of 2011 were identified from the regional mortality register. Causes of death were
coded by versions 9 and 10 of the International Classification of Diseases: CVD
mortality included codes 390–458 of ICD-9 and I00-I99 – codes of ICD-10; deaths
from CHD included codes 410–414 of ICD-9 and I20–I25 of ICD-10. During
Health Factors and Risk of Mortality
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1983–2011, there were 1,219 death cases from any cause, 589 deaths from CVD,
and 342 deaths from CHD among persons free from CHD and stroke at baseline
surveys. The mean duration of follow-up was 13.3 years.
Statistical analysis
Descriptive statistics (prevalence rates, means and standard deviations (SD)) were
calculated for variables in each survey. P,0.05 values were taken as statistically
significant. Hazard ratio (HR) and 95% confidence intervals (CI) were estimated
by the multivariate Cox proportional hazards regression for all-cause, CVD and
CHD mortality separately for men and women. The model included age, survey
year, education, alcohol consumption, antihypertensive treatment, hypoglycemic
therapy, lipid lowering treatment, and all six risk factors (smoking habits, body
weight, BP, total cholesterol, fasting glucose, physical activity). We also presented
model including the number of cardiovascular health factors. The HR were
calculated and compared to the average risk in the whole population using
deviation from mean coding. The analytical sample was restricted to persons free
from CHD and stroke at baseline and having all data for variables included into
multivariate Cox models (n54,979). Data were analyzed with SPSS version 13.4
software for Windows.
Results
Age-standardized means and the prevalence rates of cardiovascular factors by
survey are presented in Table 1. All cohorts had similar age and gender
distribution whereas the educational distribution changed over time. There were
also some changes in cardiovascular risk profile. Mean fasting glucose increased
from 4.61 (1.16) to 5.79 (1.17) mmol/L comparing 1983–1984 and 2006–2008
surveys samples (p,0.05), as did the proportion of responders with fasting
glucose >6.99 mmol/l. The proportion of subjects in intermediate leisure physical
activity group decreased during the study period (p,0.05) and proportion of
subjects receiving antihypertensive treatment during the same period increased
(p50.001). The proportion of subjects with 6 healthy factors was higher in 2006–
2008 than in 1983–1984 (p50.09). On the other hand, during 25 year period, the
levels of total serum cholesterol, smoking habits, and blood pressure did not
change.
A greater number of healthy levels of cardiovascular risk factors was related to
lower all-cause mortality (all-cause mortality rate among subjects with 0 health
factors compared to subjects having 6 health factors was 21.2% and 5.0%
respectively) (Table S1). After multivariate adjustment for age, education, alcohol
intake frequency, survey, antihypertensive and lipid-lowering treatment, and
hypoglycemic therapy being never smoking and being at active level of leisure
physical activity, having BMI 25.0–29.9 kg/m2 among men and being at active
level of leisure physical activity, having intermediate BP level, fasting glucose level
Health Factors and Risk of Mortality
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Table 1. Characteristics of population and prevalence (%) of risk factors in urban population aged 45–64 years in 1983–1984 to 2006–2008.
Risk factors 1983–1984 1986–1987 1992–1993 2001–2002 2006–2008 P for
(n51682) (n51192) (n5848) (n51001) (n54486) trend
Mean age, years (SD) 54.6 (5.40) 53.9 (5.64) 54.4 (5.76) 54.2 (5.57) 56.1 (5.53) 0.30
Sex
Men 46.5 50.7 49.2 43.4 44.8 0.20
Women 53.5 49.3 50.8 56.6 55.5 0.20
Smoking status
Never 67.5 69.7 71.4 64.5 57.9 0.12
Former 14.9 11.5 14.2 14.7 17.7 0.20
Current 17.6 18.8 14.4 20.8 24.4 0.19
Leisure physical activity
Active 67.5 69.7 83.9 78.6 87.9 0.07
Intermediate 24.8 27.3 14.9 15.0 9.9 ,0.05
Inactive 7.7 4.9 1.2 6.3 2.2 0.47
BMI, kg/m2
,25.0 17.6 19.0 27.2 23.8 22.6 0.33
25.0–29.9 41.1 41.7 42.5 37.2 39.4 0.10
>30.0 41.5 39.3 30.4 39.0 38.0 0.80
Mean BMI, kg/m2 (SD) 29.5 (5.40) 29.2 (4.79) 28.3 (4.71) 29.0 (5.78) 29.0 (5.34) 0.66
Total serum cholesterol, mmol/L
,5.2 18.6 16.6 22.1 20.2 25.2 0.12
5.2–6.19 37.2 31.6 31.4 31.2 35.7 0.84
.6.2 44.4 51.8 46.6 48.6 39.1 0.42
Mean total cholesterol, mmol/L (SD) 6.14 (1.19) 6.31 (1.18) 6.26 (1.35) 6.33 (1.34) 5.98 (1.13) 0.56
Lipid-lowering treatment ND ND 0.6 1.3 7.7 0.11
Blood pressure, mm Hg
,120/80 (untreated) 8.1 13.6 8.9 14.6 11.9 0.41
120–139/80–89 or treated to ,120/80 30.9 33.4 32.6 29.7 25.8 0.11
>140/>90 61.0 53.0 58.5 55.7 62.3 0.67
Mean BP, mmHg (SD)
Systolic 143.7 (23.8) 139.4 (22.2) 142.2 (22.5) 139.3 (23.2) 138.6 (21.4) 0.18
Diastolic 88.3 (11.8) 86.6 (12.8) 89.1 (11.5) 86.3 (12.4) 90.5 (12.6) 0.59
Antihypertensive treatment 19.1 21.1 26.3 32.8 33.2 0.001
Fasting blood glucose, mmol/L
,5.55 83.7 69.3 52.9 60.6 44.9 0.08
5.55–#6.99 14.4 26.9 42.5 33.8 46.6 0.10
.6.99 1.8 3.8 4.6 5.5 8.5 ,0.05
Mean fasting glucose, mmol/L (SD) 4.61 (1.16) 5.09 (0.99) 5.39 (1.48) 5.62 (1.53) 5.79 (1.17) ,0.05
Hypoglycemic therapy 1.6 2.2 1.6 1.9 4.5 0.21
Education
Primary 26.5 18.5 12.1 1.5 2.0 ,0.01
Unfinished secondary 25.9 27.4 22.1 9.7 31.8 0.76
Secondary or college 30.0 31.6 39.7 59.4 31.6 0.43
University 17.6 22.5 26.1 29.4 34.6 ,0.01
Number of healthy levels of risk factors
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less 5.55 mmol/L among women were each associated with a significantly lower
risk of all-cause mortality (Table 2). The only factor that was not associated with
mortality in the expected fashion was total cholesterol among men; compared to
the average risk in the whole population using deviation from mean coding,
participants with cholesterol level ,5.2 mmol/L the fully adjusted HR for all-
cause mortality was significantly higher (HR 1.19, 1.05–1.36). A similar pattern
was observed for CVD mortality (Table 3) and CHD mortality (table 4) among
women. The tendency of lower but not statistically significant all-cause, CVD and
CHD risk of the intermediate cholesterol category was determined both among
men and women.
Table 5 shows the adjusted HR for all-cause, CVD and CHD mortality among
men, women, and in both sexes combined by the number of healthy levels of
cardiovascular risk factors, comparing those with average risk in the whole
population. Having favourable levels on a greater number of health factors was
associated with a lower risk of all-cause, CVD and CHD mortality, although the
trend was stronger in men and more pronounced for CVD mortality.
Discussion
To our knowledge, the present study is the first prospective investigation of the
prevalence, trends and prognostic impact of healthy levels of cardiovascular risk
factors on all-cause, CVD and CHD mortality in the Baltics. We found that only
about 1% of middle-aged urban adults in Kaunas had a low-risk profile. This
indicates the large potential for preventing cardiovascular and other non-
communicable diseases that still remains to be implemented.
After the American Heart Association (AHA) defined the concept of
cardiovascular health in the 2020 Impact Goal [21], several studies estimated the
profile of ideal or low-risk cardiovascular health using the AHA criteria in the US
and China [6, 9, 10]. The impact of favourable cardiovascular risk profile on CVD
incidence and mortality using definitions to AHA have been previously evaluated
in the US, Italy, Japan and other countries [7, 8, 23, 24].
Table 1. Cont.
Risk factors 1983–1984 1986–1987 1992–1993 2001–2002 2006–2008 P for
(n51682) (n51192) (n5848) (n51001) (n54486) trend
0 2.2 1.8 1.1 2.3 2.3 0.59
1 14.1 12.8 11.9 12.3 15.6 0.64
2 31.9 31.3 33.4 31.7 34.9 0.32
3 33.9 38.4 31.6 33.3 29.7 0.21
4 14.9 11.7 16.9 15.5 13.2 0.91
5 2.7 3.5 4.7 4.3 3.7 0.37
6 0.2 0.5 0.4 0.6 0.6 0.09
BMI – body mass index. ND – no data. SD – standard deviation.
doi:10.1371/journal.pone.0114283.t001
Health Factors and Risk of Mortality
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Our data suggest very few changes in the prevalence, distribution and mean
levels of 6 cardiovascular health factors during 25 years in this urban adult
population. Some of these changes were unfavourable (e.g. the increase in the
prevalence of unhealthy level of fasting glucose). On the other hand, there were
also positive changes, reflected by the increase of the proportion of participants
with 6 healthy levels of cardiovascular risk factors. In comparison, among the
National Health and Nutrition Examination Survey (NHANES) III participants in
the US, from 7 cardiovascular health metrics using AHA definition, for smoking
showed favourable changes: proportion of never-smokers significantly increased
from 1988–1994 to 2005–2010 [6]. For other cardiovascular health metrics,
Table 2. Adjusted hazard ratio (HR) of cardiovascular health factors and risk of all-cause mortality.
HR (95% CI)
Cardiovascular health
factor Men Women
Number of deaths/
number at risk P value
Number of deaths/
number at risk P value
Smoking status
Current 1.43 (1.26–1.62) 50/839 ,0.001 1.27 (0.83–1.93) 3/257 0.27
Former 0.93 (0.81–1.08) 39/593 0.33 0.98 (0.61–1.59) 3/164 0.94
Never 0.75 (0.66–0.86) 45/878 ,0.001 0.80 (0.60–1.08) 58/2158 0.15
Leisure physical activity
Inactive 1.16 (0.90–1.50) 11/83 0.25 1.81 (1.30–2.53) 4/58 0.001
Intermediate 1.06 (0.89–1.25) 44/427 0.52 0.84 (0.66–1.06) 14/334 0.14
Active 0.82 (0.70–0.96) 79/1800 0.011 0.66 (0.54–0.81) 46/2187 ,0.001
BMI, kg/m2
>30.0 1.03 (0.89–1.19) 50/628 0.68 1.09 (0.90–1.32) 34/1081 0.36
25.0–29.9 0.84 (0.74–0.95) 52/1076 0.006 0.88 (0.73–1.08) 21/915 0.23
,25.0 1.15 (1.00–1.32) 32/606 0.044 1.04 (0.81–1.33) 9/583 0.78
Blood pressure, mm Hg
>140/>90 1.20 (1.03–1.38) 89/1419 0.017 1.22 (0.98–1.51) 48/1357 0.07
120–139/80–89 or treated
to ,120/80
0.93 (0.80–1.09) 37/671 0.36 0.76 (0.61–0.96) 14/793 0.022
,120/80 (untreated) 0.90 (0.73–1.11) 8/220 0.31 1.08 (0.80–1.44) 2/429 0.63
Fasting glucose, mmol/L
.6.99 1.20 (0.91–1.58) 9/132 0.20 1.61 (1.09–2.41) 7/138 0.018
5.55–#6.99 0.87 (0.73–1.04) 33/900 0.12 0.80 (0.62–1.02) 16/1000 0.08
,5.55 0.96 (0.81–1.14) 92/1278 0.65 0.78 (0.61–0.999) 41/1441 0.049
Total serum cholesterol,
mmol/L
>6.2 0.90 (0.80–1.02) 54/862 0.11 1.02 (0.85–1.22) 35/1254 0.82
5.2–6.19 0.93 (0.82–1.06) 39/829 0.27 0.92 (0.75–1.13) 17/847 0.92
,5.2 1.19 (1.05–1.36) 41/619 0.008 1.06 (0.83–1.36) 12/478 0.63
Adjusted for age, education, alcohol intake frequency, study survey year, smoking status, physical activity, BMI, total cholesterol level, blood pressure,
fasting glucose level, antihypertensive treatment, hypoglycemic therapy, lipid lowering treatment. CI – confidence interval, BMI – body mass index.
doi:10.1371/journal.pone.0114283.t002
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unfavourable (BMI, fasting glucose, and healthy diet status) or no changes (blood
pressure, physical activity, and total serum cholesterol) have been detected. More
favourable trends in the prevalence of low risk factors were observed among 25–74
year-aged participants in four NHAHES surveys (from 1971–1975 to 1999–2004).
The prevalence of 3 low risk factors (out of 5) significantly improved (not
smoking, low total serum cholesterol and favourable BP) but adverse trends have
been observed for prevalence of BMI ,25.0 kg/m2 and not having diagnosed
diabetes mellitus [22].
Table 3. Adjusted hazard ratio (HR) of cardiovascular health factors and risk of CVD mortality.
HR (95% CI)
Cardiovascular health
factor Men Women
Number of deaths/
number at risk P value
Number of deaths/
number at risk P value
Smoking status
Current 1.50 (1.23–1.82) 91/839 ,0.001 1.17 (0.60–2.29) 6/257 0.65
Former 0.90 (0.73–1.11) 54/593 0.31 0.97 (0.47–2.04) 4/164 0.94
Never 0.75 (0.61–0.91) 75/878 0.003 0.88 (0.56–1.39) 115/2158 0.59
Leisure physical activity
Inactive 1.33 (0.94–1.87) 17/83 0.11 1.58 (0.95–2.64) 8/58 0.08
Intermediate 1.01 (0.79–1.28) 65/427 0.96 0.80 (0.56–1.15) 29/334 0.23
Active 0.75 (0.60–0.94) 138/1800 0.012 0.79(0.58–1.07) 88/2187 0.13
BMI, kg/m2
>30.0 1.36 (1.11–1.67) 76/628 0.003 0.93 (0.71–1.22) 70/1081 0.60
25.0–29.9 0.84 (0.70–1.02) 94/1076 0.07 0.95 (0.72–1.26) 37/915 0.74
,25.0 0.87 (0.70–1.09) 50/606 0.24 1.13 (0.79–1.62) 18/583 0.50
Blood pressure, mm Hg
>140/>90 1.44 (1.14–1.81) 150/1419 0.002 1.61 (1.13–2.29) 97/1357 0.008
120–139/80–89 or treated
to ,120/80
0.87 (0.67–1.11) 54/671 0.26 0.74 (0.50–1.09) 21/793 0.13
,120/80 (untreated) 0.80 (0.56–1.14) 16/220 0.22 0.84 (0.49–1.45) 7/429 0.53
Fasting glucose, mmol/L
.6.99 1.34 (0.90–2.02) 14/132 0.15 2.27 (1.32–3.90) 11/138 0.003
5.55–#6.99 0.75 (0.57–0.98) 57/900 0.034 0.68 (0.47–0.98) 30/1000 0.039
,5.55 0.99 (0.77–1.27) 149/1278 0.95 0.65 (0.46–0.92) 84/1441 0.015
Total serum cholesterol,
mmol/L
>6.2 1.03 (0.86–1.24) 94/862 0.76 0.93 (0.72–1.20) 75/1254 0.57
5.2–6.19 0.82 (0.67–1.01) 59/829 0.06 0.74 (0.55–1.00) 29/847 0.052
,5.2 1.18 (0.97–1.44) 67/619 0.10 1.45 (1.04–2.02) 21/478 0.028
Adjusted for age, education, alcohol intake frequency, study survey year, smoking status, physical activity, body mass index, total cholesterol level, blood
pressure, fasting glucose level, antihypertensive treatment, hypoglycemic therapy, lipid lowering treatment. CI – confidence interval, CVD – cardiovascular,
BMI – body mass index.
doi:10.1371/journal.pone.0114283.t003
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Considering the prevalence of ideal levels of cardiovascular risk factors, our
findings indicate that the distribution of cardiovascular health metrics is different
between Lithuania and other countries. Around two thirds (56.5% to 70.8%) of
participants in our study were never smokers; this is significantly higher than the
proportion of participants in other studies in US and Italy [24–26] but lower
when compared to participants in Disease Risk Evaluation and Health
Management (DREHM) study in China [6]. This, however, is mainly driven by
low prevalence of smoking in women in Lithuania. The prevalence of ideal BMI,
total serum cholesterol, BP, and fasting glucose were lower in our study than in
the above studies. Only 8.6 to 15.6% of participants met the ideal level of BP after
adjusting for age in our study. Furthermore, recently published findings from the
MONICA study showed low hypertension control in men (3.6% in 1983–1984
and 12.6% in 2001–2002) and women (3.5% and 16.6% respectively) [5]. The
prevalence of ideal level of physical activity was high (67.7 and 88.0%), compared
to other studies [6, 27]. These differences partially could be explained by the fact
that The International Physical Activity Questionnaire has been used for
measuring of physical activity only in some surveys of our dataset. Therefore we
could measure only the mean time a week spent during leisure for walking,
vigorous-intensity and moderate-intensity exercise and hard work, gardening and
other physical activities and we used our own definition of ideal, intermediate and
unhealthy level of physical activity which differ from the AHA definition and
criteria of physical inactivity used in the mentioned above studies.
In the prospective analyses, ideal or intermediate levels of most cardiovascular
health factors were associated with significantly lower all-cause, CVD and CHD
mortality, and many of these associations followed a dose-response pattern. These
findings are consistent with previous findings in other cohorts [25, 28–30].
Interestingly, we found that total cholesterol concentrations ,5.2 mmol/L were
associated with increased higher risk of mortality when compared with the average
risk in the whole population, although the NHANES III study also reported such
an association – the adjusted hazard ratio of all-cause mortality for total serum
cholesterol of ,200 mg/dL (,5.2 mmol/L) vs.>200 mg/dL (.5.2 mmol/L) was
independently associated with a significantly higher risk of all-cause mortality
(HR51.28 (95% CI 1.15–1.42) [6]. A meta-analysis of individual data from 61
prospective studies indicated, that total cholesterol was positively associated with
ischaemic heart disease mortality in middle and old age groups, however the
proportional risk reduction decrease with increasing BP, since the absolute effects
of cholesterol and BP are approximately additive [31]. The absence of an
independent positive association of total cholesterol with all-cause and CVD
mortality in our longitudinal study, is unexplained, and invites for further
research.
Most prospective studies relating ideal cardiovascular health or positive health
factors observed an inverse relationship between the number of ideal (positive)
health factors and mortality from all causes, CVD [6, 25, 30] and sudden cardiac
death [32]. Similar findings were reported for the incidence of CHD [26], CVD
[10] and stroke [24, 27]. This is consistent with our results: larger numbers of
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positive health factors were associated with lower CVD risk, although the
association was stronger among men.
To date, no studies on this important topic were reported from Central and
Eastern Europe where both the prevalence of cardiovascular risk factors and CVD
mortality rates are high. The strength of our study includes the prospective cohort
design, which makes selection and information bias unlikely. Numerator-
denominator bias is minimized trough linkage of the survey cohorts with
mortality register; the register is complete and it is very unlikely that it would miss
more than a handful of deaths. In addition, we controlled for a range of potential
Table 4. Adjusted hazard ratio (HR) of cardiovascular health factors and risk of CHD mortality.
HR (95%
CI)
Cardiovascular health factor Men Women
Number of deaths/
number at risk P value
Number of deaths/
number at risk P value
Smoking status
Current 1.32 (1.03–1.69) 50/839 0.031 1.10 (0.44–2.71) 3/257 0.84
Former 1.04 (0.81–1.35) 39/593 0.74 1.43 (0.58–3.51) 3/164 0.43
Never 0.73 (0.57–0.93) 45/878 0.013 0.64 (0.35–1.15) 58/2158 0.64
Leisure physical activity
Inactive 1.38 (0.89–2.13) 11/83 0.15 1.47 (0.71–3.05) 4/58 0.31
Intermediate 1.05 (0.78–1.42) 44/427 0.74 0.83 (0.50–1.39) 14/334 0.83
Active 0.69 (0.52–0.92) 79/1800 0.010 0.82 (0.52–1.28) 46/2187 0.82
BMI, kg/m2
>30.0 1.40 (1.09–1.81) 50/628 0.009 0.87 (0.60–1.26) 34/1081 0.46
25.0–29.9 0.76 (0.60–0.97) 52/1076 0.03 1.09 (0.73–1.61) 21/915 0.68
,25.0 0.94 (0.70–1.24) 32/606 0.64 1.06 (0.64–1.76) 9/583 0.81
Blood pressure, mm Hg
>140/>90 1.38 (1.00–1.89) 89/1419 0.048 1.62 (0.91–2.89) 48/1357 0.10
120–139/80–89 or treated to
,120/80
1.00 (0.72–1.39) 37/671 0.99 1.22 (0.66–2.24) 14/793 0.53
,120/80 (untreated) 0.73 (0.44–1.20) 8/220 0.21 0.51 (0.19–1.37) 2/429 0.18
Fasting glucose, mmol/L
.6.99 1.47 (0.88–2.46) 9/132 0.14 2.75 (1.35–5.64) 7/138 0.006
5.55–#6.99 0.71 (0.50–0.99) 33/900 0.046 0.63 (0.38–1.03) 16/1000 0.07
,5.55 0.96 (0.70–1.32) 92/1278 0.81 0.58 (0.36–0.93) 41/1441 0.025
Total serum cholesterol,
mmol/L
>6.2 0.99 (0.78–1.25) 54/862 0.91 0.75 (0.54–1.21) 35/1254 0.12
5.2–6.19 0.86 (0.67–1.11) 39/829 0.25 0.81 (0.54–1.21) 17/847 0.31
,5.2 1.18 (0.91–1.52) 41/619 0.21 1.64 (1.04–2.59) 12/478 0.033
Adjusted for age, education, alcohol intake frequency, study survey year, smoking status, physical activity, body mass index, total cholesterol level, blood
pressure, fasting glucose level, antihypertensive treatment, hypoglycemic therapy, lipid lowering treatment. CHD – coronary heart disease, CI – confidence
interval, BMI – body mass index.
doi:10.1371/journal.pone.0114283.t004
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confounding variables, including age, education, alcohol intake frequency and
study survey year. An important advantage is the high comparability with other
studies because definitions of most cardiovascular factors were identical to those
recommended by AHA or those used in other cohort studies elsewhere.
However, the present study has several limitations. Our study involved only one
assessment of the included healthy cardiovascular factors. Thus, because
participants could have misreported or changed their lifestyle, there is a potential
for exposure misclassification, which may have affected our risk estimates, most
likely towards under-estimation. Nevertheless, most cardiovascular risk factors
included in the analyses were found to be predictive for both all-cause and CVD
mortality. Some of the earlier cohort studies found that, although many variables
and risk factors changed over time, the baseline survey data remained predictive
for mortality [33]. The next problem is that physical activity and nutritional
habits in the surveys of forming our study were assessed using different
questionnaires, we were unable to evaluate physical activity and diet score as
recommended by AHA and we had to use our own ad hoc definitions. Another
limitation is that capillary blood glucose was measured in all five general
population surveys. It is likely that our measures were less reliable and less
sensitive to detect adverse effects on mortality. Finally, the present study did not
examine the national samples, but it rather included random population samples
in one urban setting.
Conclusions
The prevalence of ideal levels of all 6 easily measurable cardiovascular health
factors in this Lithuanian general population sample was low. We observed an
inverse association of most healthy levels of cardiovascular risk factors with risk of
all-cause and CVD mortality, and greater number of cardiovascular health factors
was significantly associated with lower risk of CVD mortality among men. The
strategic priority for public health is to increase the proportion of the population
with ideal levels of cardiovascular health factors in order to reduce CVD mortality.
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